Clinical Experience with Two Twice Daily Slow Release Theophylline Preparations. Relation between Serum Theophylline Concentrations,Effectiveness,Tolerability and Compliance in Elderly Patients
Restricted accessResearch articleFirst published online May, 1987
Clinical Experience with Two Twice Daily Slow Release Theophylline Preparations. Relation between Serum Theophylline Concentrations,Effectiveness,Tolerability and Compliance in Elderly Patients
The relation between serum theophylline concentrations, effectiveness, tolerability and compliance were evaluated in 14 hospitalized elderly patients with broncho-obstructive pathology, using a new twice daily sustained release theophylline suspension compared to standard twice daily slow release tablets. The results showed that the mean theophylline serum concentration remains within the therapeutic range with both preparations. No significant difference exists between the two treatments with regard to effectiveness. Tolerability and compliance of the theophylline suspension, however, were higher.
Get full access to this article
View all access options for this article.
References
1.
Webb-JohnsonDCAndrewsJLJr: Bronchodilator therapy. N Engl J Med1977; 297: 758–764.
2.
AlexanderMRDullWLKasikJE: Treatment of chronic obstructive pulmonary disease with orally biadministered theophylline. J Am Med Assoc1980; 244: 2286–2290.
3.
OgilvieRJ: Clinical pharmacokinetics of theophylline. Clin Pharmacokin1978; 3: 267–293.
4.
FishmanAP: State of the art. Chronic cor pulmonale. Am Rev Respir Dis1976; 114: 775–794.
GoodsellEBSteinHHWenzkeKJ: 8-substituted theophyllines. In vitro inhibition of 3′, 5′-cyclic adenosine monophosphate phosphodiesterase and pharmacological spectrum in mice. J Med Chem1971; 14: 1202–1205.
7.
BerdelD: Clinical pharmacology of theophylline in children. Br Med J1984; 38: 29–36.
8.
BaxterJH: Histamine release from rat mast cells by dextran: effects of adrenergic agents theophylline, and other drugs. Proc Soc Exp Biol Med1972; 141: 576–581.
9.
MarquardtDLParkerCWSullivansTJ: Potentiation of mastcells mediator release by adenosyne. J Immunol1978; 120: 871–878.
10.
JacobsMHSeniorRMKesslerG: Clinical experience with theophylline: relationship between dosage, serum concentration and toxicity. J Am Med Assoc1976; 235: 1983–1986.
11.
YannelPRChuNS: Focal seizures and aminophylline. Neurology1975; 25: 819–822.
12.
RessJ: Treatment of chronic asthma. Br Med71984; 288: 1819–1821.
13.
WeinbergerHHendelesLBighleyL: The relation of product formulation to absorption of oral theophylline. N Engl J Med1978; 299: 852–857.
14.
WoodcockAA: Theophylline prescribing, serum concentrations, and toxicity. Lancet1983; ii: 610–612.
15.
LeungPKaliskerABellTD: Variation in theophylline clearance rate with time in chronic childhood asthma. J Allergy Clin Immunol1977: 59: 440–444.
16.
WoodJHGarrettsonLK: An explanation of circadian rhythm for theophylline and other drugs. Lancet1983; ii: 570.
17.
Carratu'LSofiaMPezzaA: Effects of a new sustained-release theophylline in the treatment of broncho-asthmatic patients. G Ital Malattie Torace1986; 40: 277–282.
18.
MeyerCMStranghnABLierbermanP: A multiple-dose study of sustained release theophylline and aminophylline. Chest1978; 78: 300–303.
19.
TinkelmanD: Theophylline: the concept of sustained action. J Asthma1981; 18: 35–37.
20.
MarchioniCFPenitentiSBernocchiD: Confronto tra i livelli plasmatici di teonova sospensione e di una preparazione galenica di teofillina elisir. Biol Med (Italie)1987; 9: 61–66.
21.
KatzRMRachelefskyGSSfegelSC: Theophylline administration in children with asthma. Optimal pulmonary function and possible tolerance to chronic administration. Ann Allergy1983; 50: 23–26.
22.
WitingB: Prediction of response to theophylline in chronic bronchitis. Br J Clin Pharmacol1984; 17: 1–8.
23.
HardelPJ: Vers un renouveau de la theophylline dans le traitement de l'asthme chez l'adulte. Med Armies1980; 8: 6.
24.
HonobinDFMankuMSFranksDJ: Theophylline and bronchospasm. N Engl J Med1977; 297: 1181.
